SuperworthTheriva Biologics shares outstanding TOVX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 45.9M
- On a year earlier
- +579.6%
- more shares
Theriva Biologics had 45.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 579.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 29.1M | +945% |
| FY2024 | 2.8M | +308% |
| FY2023 | 682.5K | +8% |
| FY2022 | 630.9K | +19% |
| FY2021 | 528.2K | +525% |
| FY2020 | 84.5K | +26% |
| FY2019 | 67.2K | +25% |
| FY2018 | 53.8K | +266% |
| FY2017 | 14.7K | +24% |
| FY2016 | 11.9K | +14% |
| FY2015 | 10.4K | +39% |
| FY2014 | 7.5K | +34% |
| FY2013 | 5.6K | +18% |
| FY2012 | 4.7K | +39% |
| FY2011 | 3.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 45.9M | +580% | |
| Q1 FY26 | 41.1M | +1376% | |
| Q4 FY25 | 29.1M | +945% | |
| Q3 FY25 | 9.7M | +753% | |
| Q2 FY25 | 6.8M | +771% | |
| Q1 FY25 | 2.8M | +306% | |
| Q4 FY24 | 2.8M | +308% | |
| Q3 FY24 | 1.1M | +66% | |
| Q2 FY24 | 775.7K | +28% | |
| Q1 FY24 | 685.9K | +13% | |
| Q4 FY23 | 682.5K | +8% | |
| Q3 FY23 | 681.7K | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Theriva Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.